首页> 外文OA文献 >Microbiological changes observed over 48 weeks of treatment with inhaled liposomal ciprofloxacin in individuals with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa lung infection

【2h】

Microbiological changes observed over 48 weeks of treatment with inhaled liposomal ciprofloxacin in individuals with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa lung infection

机译：在具有非囊性纤维化支气管扩张和慢性假单胞菌铜绿素肺癌的个体中，在患有非囊性纤维化支气管扩张48周的脂质体Ciprofloxacin的微生物变化观察到48周

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
D.R. VanDevanter; I. Gonda; J. Dahms; D. Cipolla; A.M. Davis; J.D. Chalmers; J. Froehlich;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Microbiological changes observed over 48 weeks of treatment with inhaled liposomal ciprofloxacin in individuals with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa lung infection [J] . VanDevanter D. R., Gonda I., Dahms J., Clinical microbiology and infection: European Society of Clinical Microbiology and Infectious Diseases . 2019,第12期

机译：在具有非囊性纤维化支气管扩张和慢性假单胞菌铜绿素肺癌的个体中，在患有非囊性纤维化支气管扩张48周的脂质体Ciprofloxacin的微生物变化观察到48周
2. Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials [J] . Haworth Charles S., Bilton Diana, Chalmers James D., The lancet. Respiratory medicine. . 2019,第3期

机译：吸入脂质体环丙沙星在非囊性纤维化支气管扩张和慢性肺部感染与假单胞菌铜绿假单胞菌（轨道-3和轨道-4）：两相3，随机对照试验
3. Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials (vol 7, pg 213, 2019) [J] . Haworth C. S., Bilton D., Chalmers J. D. The lancet. Respiratory medicine. . 2019,第3期

机译：吸入脂质体环丙沙星在非囊性纤维化支气管扩张和慢性肺部感染与假单胞菌铜绿假单胞菌毒素-3和轨道-4患者：两相3，随机对照试验（Vol 7，PG 213,2019）
4. Population dynamics and adaptation of Pseudomonas aeruginosa during chronic lung infection in cystic fibrosis. [D] . Norgaard-Gron, Jens Christian. 2010

机译：在囊性纤维化的慢性肺部感染过程中，铜绿假单胞菌的种群动态和适应性。
5. Colistimethate sodium powder and tobramycin powder for inhalation for the treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis: systematic review and economic model. [O] . P Tappenden, S Harnan, L Uttley, -1

机译：吸入秋水仙酸钠粉和妥布霉素粉治疗囊性纤维化的慢性铜绿假单胞菌肺部感染：系统评价和经济模型。
6. Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials [O] . Charles S Haworth, Diana Bilton, James D Chalmers, 2019

机译：吸入脂质体环丙沙星在患有非囊性纤维化支气管扩张和慢性肺部感染的铜绿假单胞菌（Orbit-3和轨道-4）：两相3，随机对照试验

Microbiological changes observed over 48 weeks of treatment with inhaled liposomal ciprofloxacin in individuals with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa lung infection

著录项

相似文献

相关主题

期刊订阅